Start page Newsroom All news Newsroom type All Releases Articles year All years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 Committed to science and sustainability: What do Orion’s science-based climate targets mean? 10/7/2024 Sustainability Kerly Hiltunen was diagnosed with metastatic breast cancer: “I am very grateful to have been able to live this long” 10/1/2024 Your Health Orion’s near-term climate targets approved by the Science Based Targets initiative 9/30/2024 Press release Jenni Laukkanen: At Orion, my views are valued and that has made me more confident 9/26/2024 We are Orion Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster 9/26/2024 Press release Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology 9/25/2024 Press release Working with a migraine is exhausting – are better migraine treatments just around the corner? 9/24/2024 Your Health 213,285 Orion Corporation A shares converted into B shares 9/20/2024 Stock exchange release Alessandra Rafkin: Everything I have learnt as a Phase1 trainee at Fermion will give me a strong foundation for my future career 9/19/2024 We are Orion Can personal health data help predict future diseases? 9/18/2024 Your Health Konsta Saaranen: The Phase1 trainee programme has shown that at Orion, employees are valued and treated as equals 9/17/2024 We are Orion Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer 9/16/2024 Press release Inside information: Orion upgrades full-year outlook for 2024 9/11/2024 Stock exchange release Facility Management keeps pharmaceutical plants running 9/10/2024 We are Orion Reijo Alaluusua's prostate cancer has recurred three times: “Talking about my experiences also gives me strength” 9/2/2024 Your Health Sofia Eloranta: The Phase1 trainee programme leaves me with gratitude for my great team 8/28/2024 We are Orion AI is the drug developer’s new assistant – New drugs for pain and cancer are being developed at an accelerating pace 8/26/2024 Science and Partnering Orion Corporation: Managers’ transactions – Satu Ahomäki 8/22/2024 Managers transactions